|
ADP
|
-
|
Adenosin-Di-Phosphat
|
|
AK
|
-
|
Antikörper
|
|
AP
|
-
|
Alkalische Phosphatase
|
|
APAAP
|
-
|
Alkalische Phosphatase-Anti-Alkalische Phosphatase
|
|
APC
|
-
|
Antigen-präsentierende Zellen
|
|
ATP
|
-
|
Adenosin-Tri-Phosphat
|
|
BCIP
|
-
|
Brom-Chlor-Indolylphosphat
|
|
BPH
|
-
|
Benigne Prostatahyperplasie
|
|
CD
|
-
|
cluster of differentiation
|
|
CI
|
-
|
Konfidenzintervall
|
|
CIT
|
-
|
Chemoimmuntherapie
|
|
CR
|
-
|
complete remission
|
|
13-CRA
|
-
|
13-cis-Retinsäure
|
|
CT
|
-
|
Computertomographie
|
|
CTL
|
-
|
zytotoxische T-Lymphozyten
|
|
DC
|
-
|
dendritische Zellen
|
|
3D-CT
|
-
|
3D-Computertomographie
|
|
DGCIN
|
-
|
Deutsche Gesellschaft zur Chemoimmuntherapie des NZK
|
|
EBRT
|
-
|
External beam radiotherapy
|
|
EDTA
|
-
|
Ethylen-Diamin-Tetraazetat
|
|
ELISA
|
-
|
Enzyme linked immunosorband assay
|
|
EORTC
|
-
|
European Organization for Research and Treatment of Cancer
|
|
ER
|
-
|
endoplasmatisches Retikulum
|
|
FDA
|
-
|
Food and Drug Administration
|
|
FKS
|
-
|
fetales Kälberserum
|
|
5-FU
|
-
|
5-Fluorourazil
|
|
GKSZ
|
-
|
Ganzkörperskelettszintigraphie
|
|
Gy
|
-
|
Gray
|
|
HBSS
|
-
|
Hanks balanced salt solution
|
|
HEPES
|
-
|
Hydroxyethyl-Piperazin-Ethansulfonsäure
|
|
HPLC
|
-
|
high performance liquid chromatography
|
|
HSP
|
-
|
Hitzeschockproteine
|
|
HSP70
|
-
|
70 kDa Hitzeschockproteinfamilie
|
|
HSP72
|
-
|
72 kDa Hitzeschockprotein
|
|
HSP73
|
-
|
73 kDa Hitzeschockprotein
|
|
IFN-α2a
|
-
|
Interferon-α2a
|
|
IFN-γ
|
-
|
Interferon-γ
|
|
IgG
|
-
|
Immunglobulin G
|
|
IL-2
|
-
|
Interleukin-2
|
|
IL-12
|
-
|
Interleukin-12
|
|
IMT
|
-
|
Immuntherapie
|
|
i.v.
|
-
|
intravenös
|
|
kDa
|
-
|
kilodalton
|
|
KHCO3
|
-
|
Kaliumhydrogenkarbonat
|
|
KÖF
|
-
|
Körperoberfläche
|
|
KPI
|
-
|
Karnofsky Performance Index
|
|
LAK
|
-
|
Lymphokin aktivierte Killerzellen
|
|
LDH
|
-
|
Laktatdehydrogenase
|
|
ß-ME
|
-
|
ß-Merkapto-Äthanol
|
|
MEM
|
-
|
minimum essential medium
|
|
MgCl2
|
-
|
Magnesiumchlorid
|
|
MHC
|
-
|
major histocompatibility complex
|
|
Mio
|
-
|
Millionen
|
|
MR
|
-
|
mixed response
|
|
MRT
|
-
|
Magnetresonanztomographie
|
|
NaHCO3
|
-
|
Natriumhydrogenkarbonat
|
|
NaCl
|
-
|
Natriumchlorid
|
|
NaN3
|
-
|
Natriumnitrat
|
|
NBT
|
-
|
Nitroblau-Tetrazoliumchlorid
|
|
NED
|
-
|
no evidence of disease
|
|
NH4Cl
|
-
|
Ammoniumchlorid
|
|
NK
|
-
|
Natürliche Killerzellen
|
|
NNR
|
-
|
Nebennierenrinde
|
|
NZK
|
-
|
Nierenzellkarzinom
|
|
PBL
|
-
|
Periphere Blutlymphozyten
|
|
PBS
|
-
|
phosphat buffer saline
|
|
PCA
|
-
|
Prostatakarzinom
|
|
PD
|
-
|
progressive disease
|
|
PE
|
-
|
Phycoerythrin
|
|
PK
|
-
|
Pyruvatkinase
|
|
PMSF
|
-
|
Phenyl-Methyl-Sulfonylfluorid
|
|
PR
|
-
|
partial remission
|
|
PSA
|
-
|
prostataspezifisches Antigen
|
|
s.c.
|
-
|
subkutan
|
|
SD
|
-
|
stable disease
|
|
SDS
|
-
|
Natriumdodezylsulfat
|
|
TAP
|
-
|
transporter associated with peptide processing
|
|
TBS
|
-
|
TRIS buffered saline
|
|
TIA
|
-
|
transitorische ischämische Attacke
|
|
TNF-α
|
-
|
Tumornekrosefaktor-α
|
|
TRIS
|
-
|
Tris-(Hydroxymethyl)-Aminomethan
|
|
TU M2-PK
|
-
|
tumorspezifische Form der M2-Pyruvatkinase
|
|
UCA
|
-
|
Urothelkarzinom
|